Wouter van Rheenen

Assistant Professor

Strategic program(s):

Strategic program(s):

Contact

Research groups

Neurogenetics

Research aim

Given increasing possibilities in gene-based therapies for ALS, the overall aim of my research is to elucidate the exact genetic contribution in every patient to liability to disease.
Go to group

Clinical spectrum of motor neuron disease

Research aim

Motor neuron disease (MND) are a collection of disorder that primarily lead to progressive weakness and/or spasticity. The goal is better understand and treat the extensive clinical heterogeneity in MND.
Go to group

Recent publications

The imputation of C9orf72 repeat expansions in GWAS data Polina Merbaum, Wouter van Rheenen, Jan Veldink
2024
Assessment of risk of ALS conferred by the GGGGCC hexanucleotide repeat expansion in C9orf72 among first-degree relatives of patients with ALS carrying the repeat expansion Iris F. Van Wijk, Ruben P.A. Van Eijk, Loes Van Boxmeer, Henk Jan Westeneng, Michael A. Van Es, Wouter Van Rheenen, Leonard H. Van Den Berg, Marinus J.C. Eijkemans, Jan H. Veldink
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2024, vol. 25, p.188-196